STAT3 and acute myeloid leukemia: C188-9 is also a novel and potent STAT3 inhibitor targeting the SH2 structural domain and was first reported to inhibit granulocyte colony-stimulating factor-induced STAT3 phosphorylation and promote apoptosis in acute myeloid leukemia cell lines [78].